Vivo Bio Tech Limited Stock Price Today (NSE: VIVOBIOT)
Fundamental Score
Vivo Bio Tech Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Vivo Bio Tech Limited share price today is ₹16.83, down 2.09% on NSE/BSE as of 16 September 2026. Vivo Bio Tech Limited (VIVOBIOT) is a Small-cap company in the Biotechnology sector with a market capitalisation of ₹51.86 (Cr). The 52-week high for VIVOBIOT share price is ₹20.94 and the 52-week low is ₹16.00. The company has a Return on Equity (ROE) of -2.00% and a debt-to-equity ratio of 0.72.
Vivo Bio Tech Limited Share Price Chart — NSE/BSE Historical Performance
Vivo Bio Tech Limited share price chart: -11.54% return over the past month. 52-week high ₹20.94, 52-week low ₹16.00.
Vivo Bio Tech Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹17.30 | ₹17.30 | ₹16.01 | ₹16.83 | 7.20K (Cr) | |
| ₹16.79 | ₹17.44 | ₹16.00 | ₹17.19 | 12.19K (Cr) | |
| ₹17.00 | ₹17.37 | ₹16.50 | ₹17.13 | 33.19K (Cr) | |
| ₹18.82 | ₹18.82 | ₹16.75 | ₹16.99 | 1.12L (Cr) | |
| ₹19.01 | ₹19.20 | ₹18.46 | ₹18.64 | 8.75K (Cr) | |
| ₹19.00 | ₹19.98 | ₹18.56 | ₹19.01 | 4.33K (Cr) | |
| ₹19.00 | ₹19.08 | ₹18.42 | ₹18.99 | 39.08K (Cr) | |
| ₹18.79 | ₹19.38 | ₹18.32 | ₹18.80 | 13.08K (Cr) | |
| ₹18.16 | ₹18.79 | ₹17.80 | ₹18.70 | 11.54K (Cr) | |
| ₹18.98 | ₹18.98 | ₹17.76 | ₹18.21 | 4.25K (Cr) |
Vivo Bio Tech Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹19.00 | ₹19.98 | ₹16.00 | ₹16.83 | -11.42% | |
| ₹21.06 | ₹22.50 | ₹17.51 | ₹18.55 | -11.92% | |
| ₹22.58 | ₹26.40 | ₹18.36 | ₹21.42 | -5.14% | |
| ₹26.35 | ₹26.49 | ₹22.16 | ₹23.89 | -9.34% | |
| ₹28.80 | ₹29.39 | ₹26.05 | ₹27.56 | -4.31% | |
| ₹23.05 | ₹30.90 | ₹22.10 | ₹27.87 | +20.91% | |
| ₹26.50 | ₹27.95 | ₹20.35 | ₹21.05 | -20.57% | |
| ₹28.85 | ₹31.74 | ₹25.20 | ₹27.03 | -6.31% | |
| ₹31.60 | ₹33.40 | ₹25.60 | ₹27.30 | -13.61% | |
| ₹30.58 | ₹34.20 | ₹25.21 | ₹31.59 | +3.30% | |
| ₹33.48 | ₹35.76 | ₹29.21 | ₹30.52 | -8.84% | |
| ₹38.49 | ₹38.99 | ₹32.80 | ₹32.93 | -14.45% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Vivo Bio Tech Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Vivo Bio Tech Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of VIVOBIOT across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Strong Operating Margins (40.39%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Healthy Liquidity Position (Current Ratio: 1.51)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (-2.00%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (7.29%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Profit Decline Concern (-85.82%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Limited Growth History (0.59% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (1.66x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-24.09 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Vivo Bio Tech Limited vs Biotechnology Peers
Peer Comparison - Biotechnology
Compare Vivo Bio Tech Limited with 4 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Vivo Bio Tech LimitedVivo Bio Tech L...Selected✓ VIVOBIOT • 511509 | 8.1/100 | ₹16.83₹17 | ₹51.86₹51.86 | — — | -2.00%Poor -2.00% Poor | 7.29%Poor 7.29% Poor | 0.72Good 0.7 Good | — — | 0.59%Average 0.59% Average | 0.00% |
Anthem Biosciences LimitedAnthem Bioscien... ANTHEM • 544449 | 65.9/100 | ₹943.90₹944 | ₹53177.91₹53177.91 | 69.25Average 69.3 Average | 22.28%Excellent 22.28% Excellent | 30.37%Excellent 30.37% Excellent | 0.02Excellent 0.0 Excellent | 17.48%Excellent 17.48% Excellent | 14.00%Good 14.00% Good | 0.27% |
Advanced Enzyme Technologies LimitedAdvanced Enzyme... ADVENZYMES • 540025 | 63.4/100 | ₹300.00₹300 | ₹3359.25₹3359.25 | 20.24Average 20.2 Average | 11.05%Average 11.05% Average | 14.44%Average 14.44% Average | 0.01Excellent 0.0 Excellent | 2.91%Average 2.91% Average | 8.24%Good 8.24% Good | 1.63% |
Genesis IBRC India LtdGenesis IBRC In... GENESIS • 514336 | 9/100 | ₹27.80₹28 | ₹475.35₹475.35 | — — | -2.92%Poor -2.92% Poor | -2.92%Poor -2.92% Poor | 0.00Excellent 0.0 Excellent | — — | — — | 0.00% |
Genomic Valley Biotech LtdGenomic Valley ... GVBL • 539206 | 36.4/100 | ₹30.20₹30 | ₹8.73₹8.73 | 290.85Average 290.9 Average | 0.77%Poor 0.77% Poor | 1.02%Poor 1.02% Poor | 0.00Excellent 0.0 Excellent | 15.48%Excellent 15.48% Excellent | 5.15%Good 5.15% Good | 0.00% |
Top Biotechnology Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
Vivo Bio Tech Limited PE Ratio History
Historical price-to-earnings ratio for VIVOBIOT — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹1.51 | ₹37.13 | 24.6x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Vivo Bio Tech Limited Quarterly Performance
Latest quarterly metrics for VIVOBIOT — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
14.15%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-85.82%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
0.59%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Vivo Bio Tech Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for VIVOBIOT — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Vivo Bio Tech Limited Financial Statements
Annual income statement, balance sheet and cash flow for Vivo Bio Tech Limited (VIVOBIOT) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Vivo Bio Tech Limited
About VIVOBIOT (Vivo Bio Tech Limited)
Vivo Bio Tech Ltd is a pioneering force in preclinical research, providing comprehensive solutions for biotechnology and pharmaceutical innovation. With a steadfast commitment to s...cientific rigor and ethical practices, Vivo Bio Tech empowers its partners to navigate the complex landscape of drug development. The company's state-of-the-art facilities and expert team provide a seamless integration of services, from early-stage discovery to advanced preclinical testing. By leveraging cutting-edge technologies and innovative methodologies, Vivo Bio Tech accelerates the journey towards novel therapeutics, ultimately improving human health. Vivo Bio Tech offers an extensive suite of specialized services designed to meet the diverse needs of the industry. Core competencies include robust in vivo and in vitro studies that meticulously evaluate the safety and efficacy of novel compounds. Its focus extends to comprehensive pharmacokinetic and toxicokinetic profiling, genotoxicity assessments, and precise analytical services. The company maintains the highest standards of quality and compliance, ensuring that all research is conducted in accordance with global regulatory guidelines. This unwavering dedication to excellence allows Vivo Bio Tech to deliver reliable and reproducible data, bolstering the confidence of its partners. In addition to its core research services, Vivo Bio Tech is a trusted source for high-quality research models and resources. Its animal facility houses a variety of specific pathogen-free (SPF) laboratory animals, meticulously bred and maintained to ensure optimal health and genetic integrity. Vivo Bio Tech also specializes in the development of custom rodent models, tailored to specific research needs. Furthermore, the company offers stem cell products and specialized laboratory animal diets. This comprehensive approach allows Vivo Bio Tech to be a one-stop destination for researchers seeking to accelerate their scientific discoveries.
Company Details
Key Leadership
VIVOBIOT Share Price: Frequently Asked Questions
What is the current share price of Vivo Bio Tech Limited?
Vivo Bio Tech Limited (VIVOBIOT) trades at ₹16.83 on NSE and BSE. Market cap ₹51.86 (Cr). Educational data only.
What is the P/E ratio of Vivo Bio Tech Limited?
Vivo Bio Tech Limited has a P/E of N/Ax vs industry average 46.63x.
What is the Bull Run score for Vivo Bio Tech Limited?
Vivo Bio Tech Limited has a Bull Run score of 8.1/100 based on 25+ financial parameters.
Does Vivo Bio Tech Limited pay dividends?
Vivo Bio Tech Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Vivo Bio Tech Limited?
Vivo Bio Tech Limited has ROE of -2.00%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Vivo Bio Tech Limited?
Vivo Bio Tech Limited has debt-to-equity of 0.72.
Is Vivo Bio Tech Limited a good investment?
Bull Run gives Vivo Bio Tech Limited a score of 8.1/100. This is not investment advice — consult a SEBI-registered advisor.